Bivalirudin 16729-0275-67
- Manufacturer
- Accord Healthcare, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 7, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA206551
Need to source Bivalirudin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bivalirudin | 250 mg/5mL |
Drug Class
Anti-coagulant [EPC]Direct Thrombin Inhibitor [EPC]Anti-coagulant [EPC]
Selected Package
16729-0275-67Selected10 VIAL, SINGLE-USE in 1 CARTON (16729-275-67) / 5 mL in 1 VIAL, SINGLE-USE (16729-275-03)